OPtimal Timing of Thromboprophylaxis in Traumatic IntraCranial Haemorrhage (OPTTTICH Feasibility Study)
Latest Information Update: 26 Mar 2018
Price :
$35 *
At a glance
- Drugs Enoxaparin sodium (Primary)
- Indications Deep vein thrombosis; Pulmonary embolism
- Focus Therapeutic Use
- Acronyms OPTTTICH
- 20 Mar 2018 Status changed from active, no longer recruiting to completed.
- 09 May 2012 New trial record